Kamada Ltd. Reports 2014 Fourth Quarter And Full Year Financial Results

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and 12 months ended December 31, 2014.

“We are very pleased with our progress in the fourth quarter of 2014. Record quarterly revenues underscore our ability to execute to plan and grow our core business, while generating significant cash flow supports our robust clinical development program”

Help employers find you! Check out all the jobs and post your resume.

Back to news